Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Volume expansion with saline or albumin in children with severe malaria and acidosis
ISRCTN58063971Phase 2Completed
- Sponsor
- Imperial College London
- Start
- May 2001
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of albumin (human) and sodium chloride in malaria (3 arms), sponsored by Imperial College London. Primary endpoint: Percentage reduction in acidosis by eight hours. Started May 2001; status: completed.
02
Drugs
albumin (human)sodium chloride
03
Conditions
malaria
Beyond the preview
Go deeper on ISRCTN58063971.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN58063971.